应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06127 昭衍新药
未开盘 12-15 16:08:35
21.700
+0.420
+1.97%
最高
22.240
最低
20.540
成交量
1,431万
今开
20.540
昨收
21.280
日振幅
7.99%
总市值
162.53亿
流通市值
25.82亿
总股本
7.49亿
成交额
3.12亿
换手率
12.02%
流通股本
1.19亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 昭衍新药 12月15日卖空量成交72.86万股,卖空比例为5.09%
市场透视 · 12-15 16:30
每日卖空追踪 | 昭衍新药 12月15日卖空量成交72.86万股,卖空比例为5.09%
智通AH统计|12月15日
智通财经 · 12-15 16:15
智通AH统计|12月15日
昭衍新药午前涨超4% 本月股价已累计涨超三成
新浪港股 · 12-15 11:59
昭衍新药午前涨超4% 本月股价已累计涨超三成
“天价猴”再临CRO,20cm大红柱吹响昭衍新药股价反攻号角?
智通财经网 · 12-14 08:30
“天价猴”再临CRO,20cm大红柱吹响昭衍新药股价反攻号角?
英伟达连续布局13家企业,AI制药3个方向梳理(附列表)
投研大叔 · 12-13 19:40
英伟达连续布局13家企业,AI制药3个方向梳理(附列表)
一周港股牛熊榜 | 长飞光纤光缆周内飙34%,AI算力基建热潮推动光通信需求;轩竹生物周升28%,轩悦宁进入医保目录;第一拖拉机周升21%获高盛看好
老虎资讯综合 · 12-12
一周港股牛熊榜 | 长飞光纤光缆周内飙34%,AI算力基建热潮推动光通信需求;轩竹生物周升28%,轩悦宁进入医保目录;第一拖拉机周升21%获高盛看好
每日卖空追踪 | 昭衍新药 12月12日卖空量成交67.49万股,卖空比例为2.59%
市场透视 · 12-12
每日卖空追踪 | 昭衍新药 12月12日卖空量成交67.49万股,卖空比例为2.59%
智通AH统计|12月12日
智通财经 · 12-12
智通AH统计|12月12日
异动快报:昭衍新药(603127)12月12日11点0分触及涨停板
证券之星 · 12-12
异动快报:昭衍新药(603127)12月12日11点0分触及涨停板
CRO概念震荡走高 昭衍新药涨停
每日经济新闻 · 12-12
CRO概念震荡走高 昭衍新药涨停
昭衍新药再涨超10%!实验猴近期价格暴涨,机构称供需缺口或持续放大
老虎资讯综合 · 12-12
昭衍新药再涨超10%!实验猴近期价格暴涨,机构称供需缺口或持续放大
港股异动 | 昭衍新药(06127)再涨超11% 实验猴面临涨价、缺货 安评CRO有望迎边际改善
智通财经 · 12-12
港股异动 | 昭衍新药(06127)再涨超11% 实验猴面临涨价、缺货 安评CRO有望迎边际改善
CRO概念股普涨 昭衍新药涨5.94% 实验猴价格递增侧面印证CRO行业订单回暖
金吾资讯 · 12-11
CRO概念股普涨 昭衍新药涨5.94% 实验猴价格递增侧面印证CRO行业订单回暖
港股异动 | 昭衍新药(06127)再涨超7% 实验猴价格迎来暴涨 供需缺口或持续放大
智通财经 · 12-11
港股异动 | 昭衍新药(06127)再涨超7% 实验猴价格迎来暴涨 供需缺口或持续放大
港股生物医药股盘初走高!昭衍新药涨超7%,荣昌生物涨超6%
老虎资讯综合 · 12-11
港股生物医药股盘初走高!昭衍新药涨超7%,荣昌生物涨超6%
智通港股解盘 | 利空因素偏多资金撤离 乏善可陈个股行情为主
智通财经 · 12-09
智通港股解盘 | 利空因素偏多资金撤离 乏善可陈个股行情为主
每日卖空追踪 | 昭衍新药 12月09日卖空量成交212.51万股,卖空比例为12.12%
市场透视 · 12-09
每日卖空追踪 | 昭衍新药 12月09日卖空量成交212.51万股,卖空比例为12.12%
港股昭衍新药涨超10%
每日经济新闻 · 12-09
港股昭衍新药涨超10%
港股异动 | 昭衍新药(06127)涨超10% 实验猴近期价格暴涨 机构称供需缺口或持续放大
智通财经 · 12-09
港股异动 | 昭衍新药(06127)涨超10% 实验猴近期价格暴涨 机构称供需缺口或持续放大
医疗服务板块拉升,昭衍新药涨停
E公司 · 12-09
医疗服务板块拉升,昭衍新药涨停
暂无数据
公司概况
公司名称:
昭衍新药
所属市场:
SEHK
上市日期:
--
主营业务:
北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":21.7,"timestamp":1765786115007,"preClose":21.28,"halted":0,"volume":14305036,"delay":0,"floatShares":118995206,"shares":749000000,"eps":0.11052717594322004,"marketStatus":"未开盘","change":0.42,"latestTime":"12-15 16:08:35","open":20.54,"high":22.24,"low":20.54,"amount":312121331,"amplitude":0.079887,"askPrice":21.78,"askSize":5900,"bidPrice":21.7,"bidSize":20300,"shortable":3,"etf":0,"ttmEps":0.3528193246871499,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":0,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":21.28,"dividendRate":0.001507,"openAndCloseTimeList":[[1765762200000,1765771200000],[1765774800000,1765785600000]],"volumeRatio":1.2220177225752173,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":35.5,"timestamp":1765782000000,"preClose":34.35,"halted":0,"volume":59553800,"delay":0,"premium":"-44.70"}},"requestUrl":"/m/hq/s/06127/tweets","defaultTab":"tweets","newsList":[{"id":"2591624072","title":"每日卖空追踪 | 昭衍新药 12月15日卖空量成交72.86万股,卖空比例为5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591624072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591624072?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:30","pubTimestamp":1765787435,"startTime":"0","endTime":"0","summary":"昭衍新药北京时间12月15日,涨1.97%,卖空量成交72.86万股,较上一交易日减少31.85%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163603a6a4598e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163603a6a4598e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2591616750","title":"智通AH统计|12月15日","url":"https://stock-news.laohu8.com/highlight/detail?id=2591616750","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591616750?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:15","pubTimestamp":1765786506,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止12月15日收盘,东北电气、京城机电股份、弘业期货分列AH溢价率前三位,溢价率分别为900.00%、266.67%、265.78%;宁德时代、招商银行、恒瑞医药分列AH溢价率末三位,溢价率分别为-11.03%、-0.77%、1.62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01618","00317","00038","02218","00548","00553","01812","02338","BK1562","IE00B29SXG58.USD","03143","LU1504937902.USD","01349","03750","BK1594","399300","00916","00177","BK1565","01339","02359","01528","01057","03678","03968","06826","159982","01988","LU0244354667.USD","01108","LU0823426480.USD","02238","02865","LU0886674414.USD","06818","00300","LU0348827113.USD","LU1105468828.SGD","LU1522347837.USD","00638","02899","01033","03606","01276","00042","06127","00187"],"gpt_icon":1},{"id":"2591269466","title":"昭衍新药午前涨超4% 本月股价已累计涨超三成","url":"https://stock-news.laohu8.com/highlight/detail?id=2591269466","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591269466?lang=zh_cn&edition=full","pubTime":"2025-12-15 11:59","pubTimestamp":1765771140,"startTime":"0","endTime":"0","summary":" 昭衍新药午前涨超4%,本月股价已累计涨超三成。截至发稿,股价上涨4.23%,报22.18港元,成交额2.11亿港元。 根据北京商报,12月9日实验猴价格呈加速上涨趋势,大约14万元/只。 据方正证券测算,以昭衍新药为例,假设按照2024年实验猴均价计入公允价值8.49万/只,2025Q4价格提升至14万/只,假设猴场出栏率为17%,按照已知23200只猴测算,毛估计2025年新增公允价值约2.2亿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-12-15/doc-inhawauf3941208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603127","BK0216","BK1576","06127","BK1141"],"gpt_icon":0},{"id":"2591637009","title":"“天价猴”再临CRO,20cm大红柱吹响昭衍新药股价反攻号角?","url":"https://stock-news.laohu8.com/highlight/detail?id=2591637009","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591637009?lang=zh_cn&edition=full","pubTime":"2025-12-14 08:30","pubTimestamp":1765672226,"startTime":"0","endTime":"0","summary":"在股价阴跌了4个多月后,昭衍新药靠着一根“20cm大红柱”将市场目光重新拉回到这家安评龙头以及近期再度暴涨的“猴价”上。但实际上,昭衍新药此次股价新高之路并不平坦。12月12日一根“20cm大红柱”则将昭衍新药收盘价拉至21.25港元,也让筹码获利比例从12月11日的32.02%大幅升至12月12日的78.84%。从最新的Q3财报来看,2025年前三季度,昭衍新药新签订单金额达16.4亿元,同比增长17.1%,其中第三季度增速达24%,已出现回暖迹象。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381223.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06127","603127","BK1576","BK1141","BK0216"],"gpt_icon":0},{"id":"2591632904","title":"英伟达连续布局13家企业,AI制药3个方向梳理(附列表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2591632904","media":"投研大叔","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591632904?lang=zh_cn&edition=full","pubTime":"2025-12-13 19:40","pubTimestamp":1765626014,"startTime":"0","endTime":"0","summary":"今天介绍下AI制药,英伟达在过去2年投资13家AI药企,推出BioNeMo生物分子AI框架已经覆盖上百家药企,英硅智能ISM001-055进入临床III期,成为首个跨越临床II期的AI药物,从之前的布局到如今逐渐突破,商业价值正在逐渐被验证。从大叔个人来看,还有一些罕见病,由于患者少,研发不划算,而AI能快速低成本设计药物,让更多罕见病有药可治。近期热门文章HW组建医疗卫生军团,AI医疗爆发!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213194757a4470c58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213194757a4470c58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVD2.UK","02196","NVDD","LU2860962120.EUR","03759","LU0157215616.USD","LU0096362180.USD","SNVD.UK","LU2505996509.AUD","LU2505996681.GBP","LU2191332357.HKD","LU0158827948.USD","LU2237438978.USD","NVDY","LU1496350171.SGD","NVDA","IE0034235188.USD","LU1914381329.SGD","06821","LU0274383776.USD","IE00BDCRKT87.USD","NVD","SGXZ81514606.USD","LU1839511570.USD","LU2602419157.SGD","NVIW.SI","SG9999004303.SGD","LU2089284900.SGD","IE000ITXATA3.USD","LU1145028129.USD","LU1280957306.USD","2NVD.UK","LU0719512351.SGD","LU1988902786.USD","02359","LU2463028550.USD","LU2249611893.SGD","LU2473716301.USD","LU0320765059.SGD","NVDS","NVDX","LU2065171311.SGD","02228","NVD3.UK","NVDU","01093","IE000YTNTUN2.SGD","LU0444973449.USD","3NVD.UK","LU0308772762.SGD","LU1642822529.SGD","IE00BJJMRY28.SGD","LU2592432038.USD","06127","LU2420271590.USD","NVDS.UK"],"gpt_icon":1},{"id":"1176090511","title":"一周港股牛熊榜 | 长飞光纤光缆周内飙34%,AI算力基建热潮推动光通信需求;轩竹生物周升28%,轩悦宁进入医保目录;第一拖拉机周升21%获高盛看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1176090511","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176090511?lang=zh_cn&edition=full","pubTime":"2025-12-12 18:12","pubTimestamp":1765534337,"startTime":"0","endTime":"0","summary":"高速光模块、光纤光缆及相关配套设备的需求随之水涨船高。$轩竹生物-B$ 本周累升28.11%,轩悦宁进入医保目录,两款肿瘤产品年内密集获批轩竹生物近日宣布,创新药轩悦宁首次纳入国家基本医保药品目录。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f31f9c4b7b746092dc00ca030c9a8d42","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一周港股牛熊榜 | 长飞光纤光缆周内飙34%,AI算力基建热潮推动光通信需求;轩竹生物周升28%,轩悦宁进...","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09678","02643","HSTECH","01072","HSCEI","00108","01618","06869","00038","HSI","02591","02575","06127"],"gpt_icon":1},{"id":"2591680301","title":"每日卖空追踪 | 昭衍新药 12月12日卖空量成交67.49万股,卖空比例为2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591680301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591680301?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:30","pubTimestamp":1765528233,"startTime":"0","endTime":"0","summary":"昭衍新药北京时间12月12日,涨19.75%,卖空量成交67.49万股,较上一交易日减少19.7%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165649a69b85b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165649a69b85b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1141","BK1576"],"gpt_icon":0},{"id":"2590579662","title":"智通AH统计|12月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2590579662","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590579662?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:15","pubTimestamp":1765527305,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止12月12日收盘,东北电气、浙江世宝、京城机电股份分列AH溢价率前三位,溢价率分别为900.00%、265.58%、262.47%;宁德时代、招商银行、潍柴动力分列AH溢价率末三位,溢价率分别为-9.05%、-2.65%、6.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1993786604.SGD","02727","00553","00916","BK1539","LU0348735423.USD","01618","IE00B031J352.USD","03678","06031","LU0348788117.USD","LU0211977185.USD","03143","00317","00042","01456","03606","06818","01812","BK1522","06826","01057","00638","01988","01349","01528","02899","159982","06655","00548","06127","00300","LU0054450605.USD","LU1504937902.USD","02359","01108","LU0862451753.SGD","00187","03968","00895","02338","02238","01033","399300","00038","03750","06099","02218"],"gpt_icon":1},{"id":"2590521874","title":"异动快报:昭衍新药(603127)12月12日11点0分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2590521874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590521874?lang=zh_cn&edition=full","pubTime":"2025-12-12 11:05","pubTimestamp":1765508724,"startTime":"0","endTime":"0","summary":"证券之星12月12日盘中消息,11点0分昭衍新药触及涨停板。其所属行业医疗服务目前上涨。该股为干细胞,基因编辑,CAR-T疗法概念热股,当日干细胞概念上涨0.88%,基因编辑概念上涨0.87%,CAR-T疗法概念上涨0.34%。12月11日的资金流向数据方面,主力资金净流入7207.58万元,占总成交额6.85%,游资资金净流出1712.76万元,占总成交额1.63%,散户资金净流出5494.82万元,占总成交额5.22%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200011950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","06127","BK1576","603127","BK1141"],"gpt_icon":0},{"id":"2590864522","title":"CRO概念震荡走高 昭衍新药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2590864522","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590864522?lang=zh_cn&edition=full","pubTime":"2025-12-12 10:59","pubTimestamp":1765508340,"startTime":"0","endTime":"0","summary":"每经AI快讯,12月12日,CRO概念盘中震荡走高,昭衍新药涨停,益诺思涨近10%,美迪西、博腾股份、康龙化成、阳光诺和跟涨。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-12/doc-inhapfim7328287.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-12/doc-inhapfim7328287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1576","BK1141","603127","BK0216","06127"],"gpt_icon":0},{"id":"1178361730","title":"昭衍新药再涨超10%!实验猴近期价格暴涨,机构称供需缺口或持续放大","url":"https://stock-news.laohu8.com/highlight/detail?id=1178361730","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178361730?lang=zh_cn&edition=full","pubTime":"2025-12-12 10:13","pubTimestamp":1765505608,"startTime":"0","endTime":"0","summary":"12月12日,$昭衍新药$再涨超10%!据红星资本局报道,12月上旬,食蟹猴单价悄然跃过10万元大关。连日来,红星资本局以购猴者身份从广东、广西、云南等地多家实验猴养殖企业了解到,食蟹猴出现了供应短缺的现象,身价已涨至12、13万元。据方正证券测算,预计2025年至2027年实验猴供给大约4.90-5.24万只/年,实验猴需求量大约5.13-6.26万只/年,短期由于新药研发回暖,驱动实验猴用量提升,而供给侧短期改善难度较大,供需缺口或持续放大。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e9a0af42f55527cb14733ed30e19bd7f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","06127","BK1141"],"gpt_icon":0},{"id":"2590809526","title":"港股异动 | 昭衍新药(06127)再涨超11% 实验猴面临涨价、缺货 安评CRO有望迎边际改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2590809526","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590809526?lang=zh_cn&edition=full","pubTime":"2025-12-12 10:01","pubTimestamp":1765504888,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,昭衍新药再涨超11%,截至发稿,涨11.42%,报19.8港元,成交额1.29亿港元。消息面上,12月上旬,食蟹猴单价悄然跃过10万元大关。据红星资本局调查,从广东、广西、云南等地多家实验猴养殖企业了解到,食蟹猴出现了供应短缺的现象,身价已涨至12、13万元。华泰证券认为,昭衍新药是国内非临床安全性评价领域龙头,以过硬的服务能力持续提升海内外市场影响力。实验猴价格上升、新签订单回暖等或为后续主要催化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e9a0af42f55527cb14733ed30e19bd7f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","BK0216","06127","603127"],"gpt_icon":0},{"id":"2590934566","title":"CRO概念股普涨 昭衍新药涨5.94% 实验猴价格递增侧面印证CRO行业订单回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2590934566","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590934566?lang=zh_cn&edition=full","pubTime":"2025-12-11 10:01","pubTimestamp":1765418460,"startTime":"0","endTime":"0","summary":"金吾财讯 | CRO概念股普涨,截至发稿,昭衍新药 涨5.94%,药明康德涨3.26%,药明生物涨2.44%,康龙化成涨1.87%,泰格医药涨1.71%,金斯瑞生物科技涨1.51%。消息面上,北京商报报道称,目前3—5岁左右的食蟹猴价格已涨至14万元一只,且年内已出现供不应求的局面。据悉,实验猴一般是猕猴、食蟹猴等猕猴属动物,是医学研究不可缺少的重要实验动物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211100147a730f084&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211100147a730f084&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01548","BK1576","02269","06127","BK1141","03347","03759"],"gpt_icon":0},{"id":"2590350550","title":"港股异动 | 昭衍新药(06127)再涨超7% 实验猴价格迎来暴涨 供需缺口或持续放大","url":"https://stock-news.laohu8.com/highlight/detail?id=2590350550","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590350550?lang=zh_cn&edition=full","pubTime":"2025-12-11 09:39","pubTimestamp":1765417198,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,昭衍新药(06127)再涨超7%,截至发稿,涨7.1%,报18.56港元,成交额4256.82万港元。消息面上,据北京商报,实验猴价格迎来暴涨。12月9日从相关繁育厂商处了解到,目前3-5岁左右的食蟹猴价格已涨至14万元一只,且年内已出现供不应求的局面。据悉,昭衍新药为全球最大实验猴供应商。根据方正证券测算,预计25-27年实验猴供给大约4.90-5.24万只/年,实验猴需求量大约5.13-6.26万只/年,该行认为短期由于新药研发回暖,驱动实验猴用量提升,而供给侧短期改善难度较大,供需缺口或持续放大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06127","BK0216","BK1576","BK1141","603127"],"gpt_icon":0},{"id":"1132076924","title":"港股生物医药股盘初走高!昭衍新药涨超7%,荣昌生物涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132076924","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132076924?lang=zh_cn&edition=full","pubTime":"2025-12-11 09:38","pubTimestamp":1765417090,"startTime":"0","endTime":"0","summary":"12月11日,港股生物医药股盘初走高,$荣昌生物(09995)$涨超4%,$康方生物(09926)$、$药明生物(02269)$、$药明合联(02268)$、$药明康德(02359)$均涨超2%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5863422ac1bd6abc1efb51c1b10288a9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","09939","02269","09995","09926","06127"],"gpt_icon":0},{"id":"2590334511","title":"智通港股解盘 | 利空因素偏多资金撤离 乏善可陈个股行情为主","url":"https://stock-news.laohu8.com/highlight/detail?id=2590334511","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590334511?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:15","pubTimestamp":1765282552,"startTime":"0","endTime":"0","summary":"12月19日至20日,摩尔线程首届MUSA开发者大会将在北京中关村国际创新中心拉开帷幕。FCC给予这些公司两周时间作出回应。中国驻华盛顿大使馆未立即回应置评请求。今天市场乏善可陈,涨幅好的都是个股行情。该协议将于2025年12月31日到期,续订协议自2026年1月1日起生效,为期三年。连日来,红星资本局了解到,食蟹猴出现了供应短缺的现象,身价已涨至12、13万元。当地时间12月9日,为期两天的美联储议息会议在美国华盛顿特区正式召开。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226287529.USD","LU1008478684.HKD","06127","LU1152091754.HKD","06869","BK1109","SG9999014674.SGD","01888","LU1497733631.SGD","LU1634259391.SGD","00728","LU1808992512.USD","LU1226287875.USD","LU0164880469.USD","SG9999001051.SGD","09890","LU0039217434.USD","BK1229","SG9999006597.SGD","03800","LU1226288253.USD","LU1064131003.USD","BK1526","LU0871576103.HKD","601828","BK1607","09660","SG9999002950.SGD","01799","LU1634259557.SGD","SG9999002463.SGD","LU0052750758.USD","00762","BK1536","00941","80883","BK1594","BK1523","SG9999001069.SGD","LU0531971595.HKD","BK1506","02858","LU1152091168.USD","01618","01528","LU0320764599.SGD","BK1516","LU1497733557.USD"],"gpt_icon":1},{"id":"2590405763","title":"每日卖空追踪 | 昭衍新药 12月09日卖空量成交212.51万股,卖空比例为12.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590405763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590405763?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:30","pubTimestamp":1765269035,"startTime":"0","endTime":"0","summary":"昭衍新药北京时间12月09日,涨5.91%,卖空量成交212.51万股,较上一交易日增加2482.14%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120916355595331d3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120916355595331d3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2590395918","title":"港股昭衍新药涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590395918","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590395918?lang=zh_cn&edition=full","pubTime":"2025-12-09 10:30","pubTimestamp":1765247402,"startTime":"0","endTime":"0","summary":"每经AI快讯,港股昭衍新药(06127.HK)一度涨超10%,截至发稿,涨9.61%,报17.8港元,成交额1.72亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512093586263990.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512093586263990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","603127","BK0216","BK1141","06127"],"gpt_icon":0},{"id":"2590839310","title":"港股异动 | 昭衍新药(06127)涨超10% 实验猴近期价格暴涨 机构称供需缺口或持续放大","url":"https://stock-news.laohu8.com/highlight/detail?id=2590839310","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590839310?lang=zh_cn&edition=full","pubTime":"2025-12-09 10:12","pubTimestamp":1765246334,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,昭衍新药涨超10%,截至发稿,涨9.61%,报17.8港元,成交额1.72亿港元。消息面上,据红星资本局报道,12月上旬,食蟹猴单价悄然跃过10万元大关。连日来,红星资本局以购猴者身份从广东、广西、云南等地多家实验猴养殖企业了解到,食蟹猴出现了供应短缺的现象,身价已涨至12、13万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK0216","603127","06127","BK1141"],"gpt_icon":0},{"id":"2590285391","title":"医疗服务板块拉升,昭衍新药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2590285391","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590285391?lang=zh_cn&edition=full","pubTime":"2025-12-09 09:58","pubTimestamp":1765245534,"startTime":"0","endTime":"0","summary":"人民财讯12月9日电,医疗服务板块拉升,昭衍新药涨停,成都先导、美迪西、益诺思跟涨。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209095854a72c3855&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209095854a72c3855&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.3362},{"period":"1month","weight":0.1168},{"period":"3month","weight":-0.153},{"period":"6month","weight":0.4322},{"period":"1year","weight":1.3996},{"period":"ytd","weight":1.3253}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.0533},{"period":"3month","weight":-0.0306},{"period":"6month","weight":0.0809},{"period":"1year","weight":0.2833},{"period":"ytd","weight":0.2776}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.111186},{"month":2,"riseRate":0.75,"avgChangeRate":0.137943},{"month":3,"riseRate":0.4,"avgChangeRate":-0.007614},{"month":4,"riseRate":0.2,"avgChangeRate":-0.110118},{"month":5,"riseRate":0.8,"avgChangeRate":0.111301},{"month":6,"riseRate":0.6,"avgChangeRate":0.067356},{"month":7,"riseRate":0.8,"avgChangeRate":0.10434},{"month":8,"riseRate":0,"avgChangeRate":-0.152531},{"month":9,"riseRate":0.6,"avgChangeRate":0.016217},{"month":10,"riseRate":0.2,"avgChangeRate":-0.062992},{"month":11,"riseRate":0.4,"avgChangeRate":0.019594},{"month":12,"riseRate":0.6,"avgChangeRate":0.015153}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}